EZH2 suppresses endogenous retroviruses and an interferon response in cancers
Authors:
Open Access
- 27 December 2021
- journal article
- research article
- Published by Impact Journals, LLC in Genes & Cancer
- Vol. 12, 96-105
Abstract
Ewing sarcoma is an aggressive cancer of bone and soft tissue in children. It is characterized by the chromosomal translocation between EWS and an Ets family transcription factor, most commonly FLI1. We recently reported that Ewing sarcoma depends on the autocrine signaling mediated by a cytokine, NELL2. NELL2 signaling stimulates the transcriptional output of EWS-FLI1 through the BAF chromatin remodeling complexes. While studying the impact of NELL2 silencing on Ewing sarcoma, we found that suppression of NELL2 signaling induces the expression of endogenous retroviruses (ERVs) and LINE-1 retrotransposons, an interferon response, and growth arrest. We determined that a histone methyltransferase, EZH2, is the critical downstream target of NELL2 signaling in suppressing ERVs, LINE-1, an interferon response, and growth arrest. We show that EZH2 inhibitors induce ERVs, LINE-1, and an interferon response in a variety of cancer types. These results uncover the role for NELL2–EZH2 signaling in suppressing endogenous virus-like agents and an antiviral response, and suggest the potential utility of EZH2 inhibitors in enhancing anti-tumor immunity.Keywords
This publication has 28 references indexed in Scilit:
- An epigenetic switch ensures transposon repression upon dynamic loss of DNA methylation in embryonic stem cellseLife, 2016
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesCell, 2015
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous TranscriptsCell, 2015
- The role of DNA methylation in directing the functional organization of the cancer epigenomeGenome Research, 2015
- Molecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional TargetsAnnual Review of Pathology: Mechanisms of Disease, 2012
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationProceedings of the National Academy of Sciences, 2009
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem CellsCancer Research, 2008
- Transposable elements and the epigenetic regulation of the genomeNature Reviews Genetics, 2007
- Initial sequencing and analysis of the human genomeNature, 2001
- 5-Methylcytosine, Gene Regulation, and Cancer1983